Amorepacific said on the 10th that its self-developed Skinsight™ technology won the innovation award in the beauty tech category at CES 2026. Amorepacific has now received the CES Innovation Awards for seven consecutive years.

Skinsight is a next-generation "electronic skin" platform that analyzes the causes of skin aging in real time and offers personalized solutions. Amorepacific jointly developed it with a research team at MIT.

Amorepacific's next-generation electronic skin platform Skinsight™ technology. /Courtesy of Amorepacific

Skinsight consists of an ultra-thin sensor patch attached to the skin, an ultra-compact Bluetooth module, and an AI-based mobile application. The patch is equipped with ultra-precise sensors that detect minute movements of the skin in micrometers (μm) and simultaneously measure four aging factors: tightness, ultraviolet/blue light, temperature, and moisture.

Skin data measured through the patch is transmitted in real time via the Bluetooth module, and the AI-based mobile application integrates 24-hour lifestyle data to model complex aging factors. Through this, users can identify their individual accelerators of skin aging and, by predicting the location and degree where future wrinkles or loss of elasticity will appear, receive tailored skincare routines and products.

Skinsight improved precision by applying the "Remote Epitaxy process" developed by the MIT team led by Kim Ji-hwan and a "piezotronic sensor" structure with electronic-level sensitivity. The related technology achieves excellent breathability so it does not easily peel off even when sweating, and it adheres along the skin's curved surface to operate stably over long periods. This makes it easy to secure personalized data by tracking and observing skin changes in various environments.

Amorepacific announced the related research results in prestigious international journals such as Science and Science Advances, and registered four patents through PCT international applications and in several countries including the United States and Korea. The technology was also used to demonstrate the improvement effect on tightness of Sulwhasoo First Care Activating Serum.

Seo Byung-hwi, CTO and head of Amorepacific's R&I Center, said, "We will create a new era in which, through advanced science and technology, we predict the causes of skin aging in advance and continuously expand individual beauty to extend the vitality of the skin."

※ This article has been translated by AI. Share your feedback here.